Abbvie purchases Cerevel Therapeutics for $8.7 billion
Abbvie has announced the $8.7 billion acquisition of US-listed Cerevel Therapeutics, marking its second multi-billion dollar second acquisition in the space of week.
Date:Wednesday, 06 December 2023 10:49 pm
